Lucid Diagnostics Inc. LUCD
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 17.36% | -16.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.36% | -16.49% | |||
| Cost of Revenue | -11.08% | -12.63% | |||
| Gross Profit | 107.86% | -3.65% | |||
| SG&A Expenses | 10.53% | -11.78% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.77% | -13.83% | |||
| Operating Income | -5.67% | 13.54% | |||
| Income Before Tax | 15.98% | 14.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.98% | 14.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.98% | 14.49% | |||
| EBIT | -5.67% | 13.54% | |||
| EBITDA | -5.76% | 13.84% | |||
| EPS Basic | 52.34% | -36.27% | |||
| Normalized Basic EPS | 19.33% | 18.73% | |||
| EPS Diluted | 52.34% | -36.27% | |||
| Normalized Diluted EPS | 19.33% | 18.73% | |||
| Average Basic Shares Outstanding | 30.71% | 6.62% | |||
| Average Diluted Shares Outstanding | 30.71% | 6.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||